期刊
MEDICAL MYCOLOGY
卷 59, 期 8, 页码 763-772出版社
OXFORD UNIV PRESS
DOI: 10.1093/mmy/myaa118
关键词
resistance; transporters; efflux pumps; erogsterol; voriconazole; posaconazole; isavuconazole milbemycine
资金
- Swiss National Science Foundation (SNSF Ambizione-Score) [PZ00P3 161140]
- SantosSuarez foundation
- Swiss National Science Foundation (SNF) [PZ00P3_161140] Funding Source: Swiss National Science Foundation (SNF)
A pan-azole-resistant strain with overexpression of drug transporters was generated in vitro. The transporter inhibitor milbemycin oxime was found to inhibit drug transporters and enhance azole activity. This study provides insight into mechanisms of azole stress adaptation and proposes drug transporter inhibition as a potential therapeutic target.
Aspergillus fumigatus is the main cause of invasive aspergillosis, for which azole drugs are the first-line therapy. Emergence of pan-azole resistance among A. fumigatus is concerning and has been mainly attributed to mutations in the target gene (cyp51A). However, azole resistance may also result from other mutations (hmg1, hapE) or other adaptive mechanisms. We performed microevolution experiment exposing an A. fumigatus azole-susceptible strain (Ku80) to sub-minimal inhibitory concentration of voriconazole to analyze emergence of azole resistance. We obtained a strain with pan-azole resistance (Ku80R), which was partially reversible after drug relief, and without mutations in cyp51A, hmg1, and hapE. Transcriptomic analyses revealed overexpression of the transcription factor asg1, several ATP-binding cassette (ABC) and major facilitator superfamily transporters and genes of the ergosterol biosynthesis pathway in Ku80R. Sterol analysis showed a significant decrease of the ergosterol mass under voriconazole exposure in Ku80, but not in Ku80R. However, the proportion of the sterol compounds was similar between both strains. To further assess the role of transporters, we used the ABC transporter inhibitor milbemycine oxime (MLB). MLB inhibited transporter activity in both Ku80 and Ku80R and demonstrated some potentiating effect on azole activity. Criteria for synergism were reached for MLB and posaconazole against Ku80. Finally, deletion of asg1 revealed some role of this transcription factor in controlling drug transporter expression, but had no impact on azole susceptibility. This work provides further insight in mechanisms of azole stress adaptation and suggests that drug transporters inhibition may represent a novel therapeutic target. Lay Summary A pan-azole-resistant strain was generated in vitro, in which drug transporter overexpression was a major trait. Analyses suggested a role of the transporter inhibitor milbemycin oxime in inhibiting drug transporters and potentiating azole activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据